Reported about 15 hours ago
Abridge, an AI-driven company specializing in automating medical notes, has doubled its valuation to $5.3 billion following a successful $300 million Series E funding round led by Andreessen Horowitz. This growth comes just four months after a $250 million fundraising that valued the company at $2.75 billion. Abridge is recognized as a leader in the AI medical scribe market, leveraging its integration with Epic Systems and reporting $117 million in annual recurring revenue.
Source: YAHOO